NASDAQ$NOTV

Inotiv Inc · Q2 2026 earnings

Q2 2026 earnings · · After market close · Investor relations

Briefing

Inotiv reported fiscal Q2 2026 total revenue of $117.7M (-5% YoY) and a net loss of $32.5M (diluted loss per share $0.94).

For the three months ended March 31, 2026 (fiscal Q2), Inotiv posted total revenue of $117.7 million, down from $124.3 million, with service revenue $58.4M and product revenue $59.2M. Operating loss was $19.3 million; consolidated net loss was $32.5 million ($0.94 diluted loss per share). Discovery and safety CRO markets remain competitive.

  • Total revenue $117.7M (-5% YoY); services $58.4M; products $59.2M.
  • Operating loss $19.3M; net loss $32.5M.
  • Interest expense $14.1M on acquisition debt.
  • Other operating expense $6.6M incl. restructuring.
  • Preclinical CRO and research products integration.

Headline financials

Total Revenue

$118M

Previous: $124M-5.4%
EPS (adj)

-$0.94

Previous: -$0.44-113.6%
Net Income

-$32.5M

Previous: -$14.9M-118.4%
Operating Income

-$19.3M

Previous: -$2.94M-557.2%

Revenue & EPS history

Inotiv · Revenue · Quarterly

$118M

Q2 2026-5.4%vs Q2 2025
Beat estimate in 8 of 14 quarters(57%)
ActualEstimate

Revenue by segment

Inotiv · $158M total across 2 segments · Q3 2023

  • RMS
    $111M-17.5%
  • DSA
    $46.8M-2.3%

Forward guidance

Bookings, backlog, and synergy targets from acquisitions discussed.

Tailwinds

  • Tax benefit and cost actions partially offset losses.
  • Product and service mix diversified.

Headwinds

  • Revenue decline and operating loss.
  • High interest burden.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2026

Historical avgQ2 2026

+0.4%

Avg return

Earnings day

+3.5%

Avg return

5 days after

+5.6%

Avg return

30 days after

39%

25 / 64 earnings

Positive

+51.3%

Q4 2022

Best reaction

-35.7%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-3.6%-0.2%-72.5%
Q1 2026-14.3%-33.3%-7.1%
Q4 2025-6.3%-9.6%-42.6%
Q2 2025+11.2%+4.5%+33.8%
Q1 2025-12.9%-8.9%-41.8%
Q4 2024+0.8%-2.6%+7.4%
Q3 2024+5.0%-5.0%-15.7%
Q2 2024+0.9%-13.2%-17.0%
Q1 2024+15.0%+45.5%+126.5%
Q4 2023-24.6%-7.1%+17.2%
Q3 2023-35.7%-40.7%-49.0%
Q2 2023-7.0%+0.2%-13.1%
Q1 2023+4.5%+4.4%-30.1%
Q4 2022+51.3%+67.4%+47.4%
Q3 2022+24.9%+33.9%+16.1%
Q2 2022+42.5%+60.3%+21.1%
Q1 2022-18.7%-28.8%-47.9%
Q4 2021-13.0%+9.7%-19.8%
Q3 2021+6.5%+3.2%+13.1%
Q2 2021+4.2%+9.3%+9.6%
Q1 2021+25.2%+34.7%+48.4%
Q4 2020+20.9%+13.6%+74.3%
Q3 2020-12.8%-15.7%-10.6%
Q2 2020+6.2%+13.2%+25.4%
Q1 2020-12.3%-13.1%-20.4%
Q4 2019+13.7%+10.8%+34.5%
Q3 2019-4.8%+16.2%+73.8%
Q2 2019-2.9%-4.8%-4.3%
Q1 2019-4.9%-2.1%+31.9%
Q4 2018-2.3%-2.3%+6.8%
Q3 2018+0.0%+6.7%+7.3%
Q2 2018+0.6%-2.3%-5.2%
Q1 2018-19.6%-16.4%-15.3%
Q4 2017-3.9%-5.7%-22.1%
Q3 2017-4.0%-2.8%-9.7%
Q2 2017+6.3%+3.2%+5.7%
Q1 2017+23.1%+20.9%+64.8%
Q4 2016+10.0%-1.2%+17.5%
Q3 2016-13.6%-4.3%-18.6%
Q2 2016-6.9%
Q1 2016-14.3%
Q4 2015-3.1%
Q3 2015-8.6%
Q2 2015-1.9%
Q1 2015-5.5%
Q4 2014-7.5%
Q3 2014+15.2%
Q2 2014-2.3%
Q1 2014-9.8%
Q4 2013+9.6%
Q3 2013+25.9%
Q2 2013+9.6%
Q1 2013+3.4%
Q4 2012-5.9%
Q3 2012+4.8%
Q2 2012-7.5%
Q1 2012+0.0%
Q1 2011+0.0%
Q4 2011-3.8%
Q2 2011-3.8%
Q4 2010-4.3%
Q3 2011-4.3%
Q3 2010-4.3%
Q2 2010-3.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro